PUBLISHER: IMARC | PRODUCT CODE: 1379188
PUBLISHER: IMARC | PRODUCT CODE: 1379188
Prenatal and Newborn Genetic Testing Market Report by Product Type, Screening, Disease, End User, and Region 2023-2028
Abstract
The global prenatal and newborn genetic testing market size reached US$ 5.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.2 Billion by 2028, exhibiting a growth rate (CAGR) of 13.3% during 2022-2028. The growing demand for advanced diagnostic and screening devices, rising prevalence of congenital malformations and genetic abnormalities in newborn babies around the world, and thriving medical industry represent some of the key factors driving the market.
Prenatal and newborn genetic testing comprises blood tests, a specific type of ultrasound, and prenatal cell-free DNA screening that offers invaluable insights into the genetic makeup of unborn babies and newborns. It can identify certain birth defects, many of which are genetic disorders in unborn or newborn babies. It provides critical information to expectant parents, healthcare professionals, and researchers, enabling them to make informed decisions about the health and well-being of infants. It assists in improving patient outcomes and guiding medical interventions while enabling accurate identification of genetic variations and abnormalities during pregnancy and early infancy. It also aids in detecting various congenital conditions, such as Down syndrome, cystic fibrosis, sickle cell disease, and phenylketonuria. As it helps analyze various protein levels in the blood of parents to determine the risk for abnormal chromosome numbers in babies, the demand for prenatal and newborn genetic testing is rising across the globe.
Prenatal and Newborn Genetic Testing Market Trends:
At present, the rising demand for advanced diagnostic and screening devices among the masses across the globe represents one of the key factors supporting the growth of the market. In addition, there is an increase in the prevalence of congenital malformations and genetic abnormalities in newborn babies worldwide. This, along with the thriving medical industry, is propelling the growth of the market. Moreover, the growing demand for non-invasive prenatal screening methods due to their various benefits, such as high accuracy and precision, less pain, and fast diagnosis, as compared to conventional methods, is positively influencing the market. Besides this, the rising awareness among individuals about the benefits of prenatal and newborn genetic testing is offering lucrative growth opportunities to industry investors. Additionally, the escalating demand for prenatal and newborn genetic testing due to the increasing number of health-conscious individuals is contributing to the growth of the market. Apart from this, governing agencies of various countries are focusing on improving healthcare infrastructure to provide enhanced healthcare services to citizens. In line with this, key players are developing genetic eye tests to identify the risk of keratoconus and other corneal dystrophies in patients. Furthermore, the growing demand for cell-free DNA in maternal plasma tests to detect the risk of genetic disorders is offering a favorable market outlook.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global prenatal and newborn genetic testing market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product type, screening, disease, and end user.
Product Type Insights:
Consumables
Instruments
The report has provided a detailed breakup and analysis of the prenatal and newborn genetic testing market based on the product type. This includes consumables and instruments. According to the report, consumables represented the largest segment.
Screening Insights:
Non-invasive Prenatal Testing
Chorionic Villus Sampling
Amniocentesis
Maternal Serum Screening
A detailed breakup and analysis of the prenatal and newborn genetic testing market based on the screening has also been provided in the report. This includes non-invasive prenatal testing, chorionic villus sampling, amniocentesis, and maternal serum screening. According to the report, non-invasive prenatal testing accounted for the largest market share.
Disease Insights:
Downs Syndrome
Phenylketonuria
Cystic Fibrosis
Sickle Cell Anemia
A detailed breakup and analysis of the prenatal and newborn genetic testing market based on the disease has also been provided in the report. This includes downs syndrome, phenylketonuria, cystic fibrosis, and sickle cell anemia. According to the report, downs syndrome accounted for the largest market share.
End User Insights:
Hospital
Maternity and Specialty Clinics
Diagnostic Centers
A detailed breakup and analysis of the prenatal and newborn genetic testing market based on the end user has also been provided in the report. This includes hospital, maternity and specialty clinics, and diagnostic centers. According to the report, hospital accounted for the largest market share.
Regional Insights:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for prenatal and newborn genetic testing. Some of the factors driving the North America prenatal and newborn genetic testing market included the growing number of pregnant women undergoing genetic screening, rising awareness about various inborn genetic diseases, enhanced healthcare infrastructure, etc.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global prenatal and newborn genetic testing market. Detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, BGI Group, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., PerkinElmer Inc., Quest Diagnostics Incorporated, Ravgen Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
- How has the global prenatal and newborn genetic testing market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global prenatal and newborn genetic testing market?
- What is the impact of each driver, restraint, and opportunity on the global prenatal and newborn genetic testing market?
- What are the key regional markets?
- Which countries represent the most attractive prenatal and newborn genetic testing market?
- What is the breakup of the market based on the product type?
- Which is the most attractive product type in the prenatal and newborn genetic testing market?
- What is the breakup of the market based on the screening?
- Which is the most attractive screening in the prenatal and newborn genetic testing market?
- What is the breakup of the market based on the disease?
- Which is the most attractive disease in the prenatal and newborn genetic testing market?
- What is the breakup of the market based on the end user?
- Which is the most attractive end user in the prenatal and newborn genetic testing market?
- What is the competitive structure of the global prenatal and newborn genetic testing market?
- Who are the key players/companies in the global prenatal and newborn genetic testing market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Prenatal and Newborn Genetic Testing Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Consumables
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Instruments
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Screening
- 7.1 Non-invasive Prenatal Testing
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Chorionic Villus Sampling
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Amniocentesis
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Maternal Serum Screening
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Disease
- 8.1 Downs Syndrome
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Phenylketonuria
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Cystic Fibrosis
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Sickle Cell Anemia
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospital
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Maternity and Specialty Clinics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Diagnostic Centers
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 Drivers, Restraints, and Opportunities
- 11.1 Overview
- 11.2 Drivers
- 11.3 Restraints
- 11.4 Opportunities
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.2 BGI Group
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Bio-Rad Laboratories Inc.
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.4 F. Hoffmann-La Roche AG
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 Illumina Inc.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Laboratory Corporation of America Holdings
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Natera Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 PerkinElmer Inc.
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 Quest Diagnostics Incorporated
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 Ravgen Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.1 Abbott Laboratories
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
List of Figures
- Figure 1: Global: Prenatal and Newborn Genetic Testing Market: Major Drivers and Challenges
- Figure 2: Global: Prenatal and Newborn Genetic Testing Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 4: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Product Type (in %), 2022
- Figure 5: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Screening (in %), 2022
- Figure 6: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Disease (in %), 2022
- Figure 7: Global: Prenatal and Newborn Genetic Testing Market: Breakup by End User (in %), 2022
- Figure 8: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Region (in %), 2022
- Figure 9: Global: Prenatal and Newborn Genetic Testing (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 10: Global: Prenatal and Newborn Genetic Testing (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 11: Global: Prenatal and Newborn Genetic Testing (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 12: Global: Prenatal and Newborn Genetic Testing (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 13: Global: Prenatal and Newborn Genetic Testing (Non-invasive Prenatal Testing) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 14: Global: Prenatal and Newborn Genetic Testing (Non-invasive Prenatal Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 15: Global: Prenatal and Newborn Genetic Testing (Chorionic Villus Sampling) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 16: Global: Prenatal and Newborn Genetic Testing (Chorionic Villus Sampling) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 17: Global: Prenatal and Newborn Genetic Testing (Amniocentesis) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 18: Global: Prenatal and Newborn Genetic Testing (Amniocentesis) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 19: Global: Prenatal and Newborn Genetic Testing (Maternal Serum Screening) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 20: Global: Prenatal and Newborn Genetic Testing (Maternal Serum Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 21: Global: Prenatal and Newborn Genetic Testing (Downs Syndrome) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 22: Global: Prenatal and Newborn Genetic Testing (Downs Syndrome) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 23: Global: Prenatal and Newborn Genetic Testing (Phenylketonuria) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 24: Global: Prenatal and Newborn Genetic Testing (Phenylketonuria) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 25: Global: Prenatal and Newborn Genetic Testing (Cystic Fibrosis) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 26: Global: Prenatal and Newborn Genetic Testing (Cystic Fibrosis) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 27: Global: Prenatal and Newborn Genetic Testing (Sickle Cell Anemia) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 28: Global: Prenatal and Newborn Genetic Testing (Sickle Cell Anemia) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 29: Global: Prenatal and Newborn Genetic Testing (Hospital) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 30: Global: Prenatal and Newborn Genetic Testing (Hospital) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 31: Global: Prenatal and Newborn Genetic Testing (Maternity and Specialty Clinics) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 32: Global: Prenatal and Newborn Genetic Testing (Maternity and Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 33: Global: Prenatal and Newborn Genetic Testing (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 34: Global: Prenatal and Newborn Genetic Testing (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 35: North America: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 36: North America: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 37: United States: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 38: United States: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 39: Canada: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 40: Canada: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 41: Asia-Pacific: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 42: Asia-Pacific: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 43: China: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 44: China: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 45: Japan: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 46: Japan: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 47: India: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 48: India: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 49: South Korea: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 50: South Korea: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 51: Australia: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 52: Australia: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 53: Indonesia: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 54: Indonesia: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 55: Others: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 56: Others: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 57: Europe: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 58: Europe: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 59: Germany: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 60: Germany: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 61: France: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 62: France: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 63: United Kingdom: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 64: United Kingdom: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 65: Italy: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 66: Italy: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 67: Spain: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 68: Spain: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 69: Russia: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 70: Russia: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 71: Others: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 72: Others: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 73: Latin America: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 74: Latin America: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 75: Brazil: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 76: Brazil: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 77: Mexico: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 78: Mexico: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 79: Others: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 80: Others: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 81: Middle East and Africa: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 82: Middle East and Africa: Prenatal and Newborn Genetic Testing Market: Breakup by Country (in %), 2022
- Figure 83: Middle East and Africa: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 84: Global: Prenatal and Newborn Genetic Testing Industry: Drivers, Restraints, and Opportunities
- Figure 85: Global: Prenatal and Newborn Genetic Testing Industry: Value Chain Analysis
- Figure 86: Global: Prenatal and Newborn Genetic Testing Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Prenatal and Newborn Genetic Testing Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
- Table 3: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Screening (in Million US$), 2023-2028
- Table 4: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Disease (in Million US$), 2023-2028
- Table 5: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by End User (in Million US$), 2023-2028
- Table 6: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 7: Global: Prenatal and Newborn Genetic Testing Market: Competitive Structure
- Table 8: Global: Prenatal and Newborn Genetic Testing Market: Key Players
